Xiaochen Dai
Impact in
- Epidemiology top 0.1%
- Acute Ischemic Stroke Management
Papers in
- Epidemiology 25
- Ophthalmology and Visual Impairment Studies 8
- Physiology 13
- Smoking Behavior and Cessation 10
- Co-authors
- Emmanuela E. Gakidou (7 shared papers)Alan D López (1 shared paper)Xiaolin Xu (14 shared papers)Rodrigo Martin Carrillo-Larco (5 shared papers)Fang Liu (3 shared papers)Joseph M. Unger (3 shared papers)Hong Xiao (3 shared papers)Shiva Raj Mishra (4 shared papers)
- Journals
- The Lancet (30 papers)The Lancet Public Health (13 papers)The Lancet Global Health (9 papers)The Lancet Infectious Diseases (9 papers)The Lancet Neurology (6 papers)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Xiaochen Dai
136 papers receiving 58.5k citations
Xiaochen Dai's Hit Papers
Peers
Comparison fields: 5 of 221
- Applied Microbiology and Biotechnology 691
- Epidemiology 7.1k
- Rehabilitation 1.3k
- Cardiology and Cardiovascular Medicine 4.6k
- Psychiatry and Mental health 3.3k
Countries citing papers authored by Xiaochen Dai
This map shows the geographic impact of Xiaochen Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Dai more than expected).
Fields of papers citing papers by Xiaochen Dai
This network shows the impact of papers produced by Xiaochen Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Dai. The network helps show where Xiaochen Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 Hit paper breakdown → | 2020 | 8081 |
| 2 | Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2021 | 5410 |
| 3 | Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic Hit paper breakdown → | 2021 | 3761 |
| 4 | Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 3606 |
| 5 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 3041 |
| 6 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2997 |
| 7 | Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study Hit paper breakdown → | 2020 | 2170 |
| 8 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1965 |
| 9 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1712 |
| 10 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1679 |
| 11 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 1526 |
| 12 | Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 Hit paper breakdown → | 2017 | 1463 |
| 13 | Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Hit paper breakdown → | 2021 | 1461 |
| 14 | Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2021 | 1174 |
| 15 | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1152 |
| 16 | Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 1112 |
| 17 | Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 970 |
| 18 | Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study Hit paper breakdown → | 2020 | 952 |
| 19 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 948 |
| 20 | Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2021 | 878 |
About Xiaochen Dai
Xiaochen Dai is a scholar working on Epidemiology, Physiology, Demography, Health and Infectious Diseases, having authored 148 papers that have together received 60.3k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (10 papers), Ophthalmology and Visual Impairment Studies (8 papers), Insurance, Mortality, Demography, Risk Management (8 papers), Global Cancer Incidence and Screening (6 papers), Global Health and Epidemiology (5 papers), Cardiovascular Health and Risk Factors (5 papers), Global Maternal and Child Health (5 papers) and HIV/AIDS Research and Interventions (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (691 citations), Epidemiology (7.1k citations), Rehabilitation (1.3k citations), Cardiology and Cardiovascular Medicine (4.6k citations) and Psychiatry and Mental health (3.3k citations). Xiaochen Dai has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Emmanuela E. Gakidou, Alan D López, Xiaolin Xu, Rodrigo Martin Carrillo-Larco, Fang Liu, Joseph M. Unger, Hong Xiao, Shiva Raj Mishra, Orvalho Joaquim Augusto and Bradley H. Wagenaar. Their work appears in journals such as The Lancet, The Lancet Public Health, The Lancet Global Health, The Lancet Infectious Diseases and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.